Trial Profile
The efficacy and tolerability of rotigotine in patients with antipsychotic-induced extrapyramidal symptoms
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Mar 2014
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Paralysis; Parkinson's disease; Psychomotor agitation
- Focus Therapeutic Use
- 12 Mar 2014 New trial record